Topic

Bruce Dembofsky is director, Innovations and Partnerships, at Avantor.

Tola Olorunnisola is vice-president of Innovation, Marketing & Digital, at Avantor.

Articles

Integrating digital technologies into lab environments can ease workflow and enhance data capture for researchers.

Lab Digitalization: From Source to Scientist 

Chris Spivey is the editorial director of 

FDA continues efforts to incentivize drug manufacturers to follow higher data integrity requirements.

Ensuring CGMP Standards for Data Integrity

Thomas A. Little is president, Thomas A. Little Consulting and BioAssay Sciences, 12401 North Wildflower Lane, Highland, Utah 84003, USA, drlittle@dr-tom.com.

Daniel S. Harding is a principle consultant of Bioassay Sciences.

Ensuring reliable analytical methods and bioassays requires a well-thought-out strategy for evaluating method validity and systems suitability.

Establishing Systems Suitability and Validity Criteria for Analytical Methods and Bioassays

Feliza Mirasol is the science editor for 

The increased flow of data from laboratory studies requires a data management strategy to optimize study success. 

Strategic Management is Growing Increasingly Important for Larger Quantities of Generated Data

Open communication and transparency coupled with technical expertise foster strong long-term manufacturing partnerships.

Selecting the Right-Fit Partner for Biotherapeutic Development

Agnes Shanley is senior editor of Pharmaceutical Technology.

As mergers continue and operations become more complex, simplifying procedures and training can prevent costly morale, quality, and compliance problems.

Human-Centered Work: How Pharma Can Move  to a Blame-Free Culture

Sharp has invested US$650,000 into enhancing its Interactive Response Technology (IRT) solution.


Sharp Invests in Interactive Response Technology Solution

Melanie Zerulla-Wernitz is team leader project & service analytics,Vetter Pharma-Fertigung GmbH & Co. KG.

Novel analytical methods may help biologics manufacturers respond to stricter regulations on particulate matter.


Analysis of Sub-Visible Particles

A look at some best practices to ensure that quality control is maintained in the client–vendor relationship.

Ensuring Quality Control in Vendor Relationships

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has made two significant changes to its new 2019 Code of Practice with the aim of boosting business integrity on a global scale.

Best Practices